 Features |
Welcome to
OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.
|
| Sponsors |
|
| Links |
CDE-Directory - A Comprehensive Guide to Continuing Dental Education
OsseoNews - The World of Implant Dentistry Online
PalmDMD - PDA's in clinical dentistry
Medgadget - Emerging Medical Technologies
PalmDDS - PDA's in clinical dentistry
CurrentJournals - Keeping you updated Automatically - Keywords, Journals, Authors delivered weekly in an easy to read PDF format
|
|
Sweden`s MPA restricts sale of NobelDirect and NobelPerfect |
Posted by:Editor
on Wednesday January 24th, 2007
|
The Swedish Medical Products Agency investigation of the dental implants NobelDirect and NobelPerfect show that there can be deficiencies in the instructions for use for the products.The MPA decision directs Nobel Biocare to clearly describe possible causes for the breakdown of the jawbone in the instructions for use and training programs. In addition, the company must describe how the risk for breakdown can be avoided. In sales and promotion information and instructions for use, the company shall indicate the user qualifications and skills required so that a dentist can use the implants safely. Nobel Biocare may not actively market the dental implants until the information activities are carried out.
The MPA`s report gives an interesting insight into the basis and timeline of this investigation.
More
 MPA`s Market surveillance of dental implants NobelDirect and NobelPerfect <<< Back  E-Mail This Topic: Implant Design
|
|
 |
! There are no comments posted for this item yet.
| |
